Skip to main content

News

April 07, 2020
Don't miss this special live presentation on Managing Interventional Oncology in the Time of COVID-19, featuring insight by #CIO2020 Course Director, Edward Kim, MD.
August 25, 2018
A recent study looked at the potential effectiveness of genomic profiling into predicting radioembolization outcome in patients with breast cancer metastatic to the liver with PI3K pathway mutation.
August 19, 2018
A new study compared overall survival for patients with early-stage non–small cell lung cancer treated with either radiofrequency ablation or stereotactic body radiotherapy.
August 14, 2018
Patients with small renal masses who are poor candidates for nephron-sparing surgery may benefit from radiofrequency ablation performed percutaneously.
August 14, 2018
Results of a retrospective review found that biopsy results of renal masses rarely obviated the need for subsequent ablation and can safely be performed alongside image-guided tumor ablation.
August 07, 2018
Liver resection was found to have significant survival benefits over TACE in patients with Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.
July 31, 2018
In a recent systemic review and meta-analysis, researchers evaluated preoperative strategies for their ability to effectively increase resectability rates in HCC.
July 26, 2018
A commercially available 3-dimensional (3D) workstation and liver analysis software can be useful for estimating the embolic area in conventional transarterial chemoembolization for hepatocellular carcinoma.
July 24, 2018
A recent study compared outcomes for thermal ablation versus nephrectomy for renal cell carcinoma.
July 17, 2018
Some patients with unresectable hepatocellular carcinoma (HCC) have prolonged survival after treatment with yttrium-90 radioembolization.
July 11, 2018
The study assessed whether patients with unresectable ICC can benefit from transarterial Y-90 glass microsphere radioembolization.
Back to Top